Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

(R)-Flecainide

(R)-Flecainide is listed in the pharmaceutical impurity collection under CAS 99495-90-6. Its represented structure has formula C17H20F6N2O3 and a calculated molecular weight of 414.35 g/mol.

2D chemical structure

O H N N H O F F F O F F F ( R )

Chemical identity

Catalog name
(R)-Flecainide
Common name
(R)-Flecainide
Chemical name
N-[[(2R)-piperidin-2-yl]methyl]-2,5-bis(2,2,2-trifluoroethoxy)benzamide
CAS
99495-90-6
SMILES
O=C(NC[C@H]1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F
InChI
InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)/t11-/m1/s1
InChIKey
DJBNUMBKLMJRSA-LLVKDONJSA-N

Record ID: A346a4134628c

Computed properties

C17H20F6N2O3 Molecular formula
414.346 g/molMolecular weight
414.1378 DaMonoisotopic exact mass
59.59 ŲTopological polar surface area
3.4407 Calculated LogP (Wildman–Crippen)
87.5169 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H N O 0 5 10 15 20 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight414.34672.37
Calculated LogP (Wildman–Crippen)3.440769.85
Topological polar surface area59.5940.41
Hydrogen-bond acceptors450.68
Hydrogen-bond donors264.87
Rotatable bonds (strict)776.94

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC17H20F6N2O3dimensionless
Molecular weight414.346g/mol
Monoisotopic exact mass414.1378Da
Topological polar surface area59.59Ų
Calculated LogP (Wildman–Crippen)3.4407dimensionless
Molar refractivity (Wildman–Crippen)87.5169cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors2count
Rotatable bonds (strict)7count
Heavy atoms28count
Heteroatoms11count
Rings2count
Aromatic rings1count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.5882fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area156.9215Ų
Valence electrons158count
Radical electrons0count
Bertz complexity657.2733index
Balaban J2.1066index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for (R)-Flecainide

Qualification and safety assessment of (R)-Flecainide

Explore toxicological qualification of (R)-Flecainide and ICH M7 mutagenic impurity assessment of (R)-Flecainide for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for (R)-Flecainide and acceptable intake and limit justification for (R)-Flecainide. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for (R)-Flecainide

Explore Altox services and software through the Altox Pharma-Hub.